Literature DB >> 29042315

IL-1β reduces GluA1 phosphorylation and its surface expression during memory reconsolidation and α-melanocyte-stimulating hormone can modulate these effects.

Ivana Machado1, Helgi B Schiöth2, Mercedes Lasaga3, Teresa Scimonelli4.   

Abstract

Pro-inflammatory cytokines can affect cognitive processes such as learning and memory. Particularly, interleukin-1β (IL-1β) influences hippocampus-dependent memories. We previously reported that administration of IL-1β in dorsal hippocampus impaired contextual fear memory reconsolidation. This effect was reversed by the melanocortin alpha-melanocyte-stimulating hormone (α-MSH). Our results also demonstrated that IL-1β produced a significant decrease in glutamate release from dorsal hippocampus synaptosomes after reactivation of the fear memory. Therefore, we investigated whether IL-1β administration can affect GluA1 AMPA subunit phosphorylation, surface expression, and total expression during reconsolidation of a contextual fear memory. Also, we studied the modulatory effect of α-MSH. We found that IL-1β reduced phosphorylation of this subunit at Serine 831 and Serine 845 60 min after contextual fear memory reactivation. The intrahippocampal administration of IL-1β after memory reactivation also induced a decrease in surface expression and total expression of GluA1. α-MSH prevented the effect of IL-1β on GluA1 phosphorylation in Serine 845, but not in Serine 831. Moreover, treatment with α-MSH also prevented the effect of the cytokine on GluA1 surface and total expression after memory reactivation. Our results demonstrated that IL-1β regulates phosphorylation of GluA1 and may thus play an important role in modulation of AMPAR function and synaptic plasticity in the brain. These findings further illustrate the importance of IL-1β in cognition processes dependent on the hippocampus, and also reinforced the fact that α-MSH can reverse IL-1β effects on memory reconsolidation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPA; Alpha-melanocyte-stimulating hormone (α- MSH); GluA1; Hippocampus; Interleukin-1-beta (IL-1β); Memory reconsolidation; p-Ser831 GluA1; p-Ser845 GluA1

Mesh:

Substances:

Year:  2017        PMID: 29042315     DOI: 10.1016/j.neuropharm.2017.09.041

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  C2-lacking isoform of Nedd4-2 regulates excitatory synaptic strength through GluA1 ubiquitination-independent mechanisms.

Authors:  Jiuhe Zhu; Kwan Young Lee; Tiffany T Jong; Nien-Pei Tsai
Journal:  J Neurochem       Date:  2019-08-25       Impact factor: 5.372

2.  Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation.

Authors:  Paola Leone; Gergana Mincheva; Tiziano Balzano; Michele Malaguarnera; Vicente Felipo; Marta Llansola
Journal:  Biomedicines       Date:  2022-05-28

3.  Hyperammonemia alters membrane expression of GluA1 and GluA2 subunits of AMPA receptors in hippocampus by enhancing activation of the IL-1 receptor: underlying mechanisms.

Authors:  Lucas Taoro-Gonzalez; Yaiza M Arenas; Andrea Cabrera-Pastor; Vicente Felipo
Journal:  J Neuroinflammation       Date:  2018-02-08       Impact factor: 8.322

Review 4.  Depression following a traumatic brain injury: uncovering cytokine dysregulation as a pathogenic mechanism.

Authors:  Colleen N Bodnar; Josh M Morganti; Adam D Bachstetter
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

5.  Severe inflammation in new-borns induces long-term cognitive impairment by activation of IL-1β/KCC2 signaling during early development.

Authors:  Donghang Zhang; Yujiao Yang; Yaoxin Yang; Jin Liu; Tao Zhu; Han Huang; Cheng Zhou
Journal:  BMC Med       Date:  2022-07-27       Impact factor: 11.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.